Diagnostic Radioisotopes Market, By Radioisotope (Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, Others ), By Application (Diagnostic Application and Therapeutic Application), By Imaging Modality (SPECT, PET, Beta Emitters), By Di
Diagnostic Radioisotopes Market, By Radioisotope (Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, Others ), By Application (Diagnostic Application and Therapeutic Application), By Imaging Modality (SPECT, PET, Beta Emitters), By Disease Indication (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
Global diagnostic radioisotopes market is witnessing significant growth due to increasing prevalence of chronic diseases, advancements in medical imaging technology, and rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.
Market Dynamics:
Global diagnostic radioisotopes market are influenced by several factors. Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders boosts demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.
However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. The limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.
Despite these challenges, the market presents several opportunities for growth. Increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to boost demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.
For instance, on March 16, 2023, Telix Pharmaceuticals Limited., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved a supplementary New Drug Application (sNDA) for Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) to enable its use for the selection of patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed therapy is indicated.
Key features of the study:
This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diagnostic radioisotopes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Cardinal Health, Lantheus Holdings, Inc., Bayer AG, Bracco, Eckert & Ziegler, Nordion (Canada) Inc., NTP Radioisotopes, Curium, Jubilant Life Sciences Ltd, IRE, Isotopia Molecular Imaging Ltd., Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., Sumitomo Heavy Industries, Ltd., and Telix Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market
Detailed Segmentation:
By Radioisotope
Technetium-99m
Thallium-201
Gallium-67
Iodine-123
FDG
Rubidium-82
Others
By Application
Diagnostic Application
Therapeutic Application
By Imaging Modality
SPECT
PET
Beta Emitters
By End User
Hospitals
Specialty Clinics
Diagnostic Centers
Academic & Research Institutes
Others
By Indication
Oncology
Cardiology
Neurology
Thyroid
Orthopedic
Endocrinology
Others
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Top companies in Global Diagnostic Radioisotopes Market
GE Healthcare
Siemens Healthineers
Koninklijke Philips N.V.
Cardinal Health
Lantheus Holdings, Inc.
Bayer AG
Bracco
Eckert & Ziegler
Nordion (Canada) Inc.
NTP Radioisotopes
Curium
Jubilant Life Sciences Ltd
IRE
Isotopia Molecular Imaging Ltd.
Mallinckrodt Nuclear Medicine LLC
Jubilant DraxImage Inc.
Sumitomo Heavy Industries, Ltd.
Telix Pharmaceuticals Limited
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Diagnostic Radioisotopes, By Radioisotope
Market Diagnostic Radioisotopes, By Application
Market Diagnostic Radioisotopes, By Imaging Modality
Market Diagnostic Radioisotopes, By Indication
Market Diagnostic Radioisotopes, By End User
Market Diagnostic Radioisotopes, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
Restraints
High cost of diagnostic radioisotopes
Opportunities
Increasing adoption of hybrid imaging techniques
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Diagnostic Radioisotopes Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Technetium-99m
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Thallium-201
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Gallium-67
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Iodine-123
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
FDG
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Rubidium-82
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Diagnostic Radioisotopes Market, By Application, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
Diagnostic Application
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Therapeutic Application
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
SPECT
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
PET
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Beta Emitters
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Diagnostic Radioisotopes Market, By Indication, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Cardiology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Thyroid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Orthopedic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Endocrinology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
9. Global Diagnostic Radioisotopes Market, By End User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019– 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Academic & Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
10. Global Diagnostic Radioisotopes Market, By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2019-2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,( US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa
11. Competitive Landscape
GE Healthcare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Siemens Healthineers
Koninklijke Philips N.V.
Cardinal Health
Lantheus Holdings, Inc.
Bayer AG
Bracco
Eckert & Ziegler
Nordion (Canada) Inc.
NTP Radioisotopes
Curium
Jubilant Life Sciences Ltd
IRE
Isotopia Molecular Imaging Ltd.
Mallinckrodt Nuclear Medicine LLC
Jubilant DraxImage Inc.
Sumitomo Heavy Industries, Ltd.
Telix Pharmaceuticals Limited
Analyst Views
12. Section
Research Methodology
About us
*Browse 47 market data tables and 50 figures on “Global Diagnostic Radioisotopes Market” - Global forecast to 2030